Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Jan, 2015 | Pages:
46 | Publisher: Global Markets Direct
Industry: Pharmaceuticals & Healthcare | Report Format: Electronic (PDF)
Typhoid Fever - Pipeline Review, H1 2015 Summary Global Markets Direct's, 'Typhoid Fever - Pipeline Review, H1 2015', provides an overview of the Typhoid Fever's therapeutic pipeline. This report provides comprehensive information on the therapeutic development for Typhoid Fever, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Typhoid Fever and special features on late-stage and discontinued projects. Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease. Scope - The report provides a snapshot of the global therapeutic landscape of Typhoid Fever - The report reviews key pipeline products under drug profile section which includes, product description, MoA and R&D brief, licensing and collaboration details & other developmental activities - The report reviews key players involved in the therapeutics development for Typhoid Fever and enlists all their major and minor projects - The report summarizes all the dormant and discontinued pipeline projects - A review of the Typhoid Fever products under development by companies and universities/research institutes based on information derived from company and industry-specific sources - Pipeline products coverage based on various stages of development ranging from pre-registration till discovery and undisclosed stages - A detailed assessment of monotherapy and combination therapy pipeline projects - Coverage of the Typhoid Fever pipeline on the basis of target, MoA, route of administration and molecule type - Latest news and deals relating related to pipeline products Reasons to buy - Provides strategically significant competitor information, analysis, and insights to formulate effective R&D development strategies - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Develop strategic initiatives by understanding the focus areas of leading companies - Identify and understand important and diverse types of therapeutics under development for Typhoid Fever - Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline - Devise corrective measures for pipeline projects by understanding Typhoid Fever pipeline depth and focus of Indication therapeutics - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Modify the therapeutic portfolio by identifying discontinued projects and understanding the factors that drove them from pipeline
Table of Contents Table of Contents 2 List of Tables 4 List of Figures 4 Introduction 5 Global Markets Direct Report Coverage 5 Typhoid Fever Overview 6 Therapeutics Development 7 Pipeline Products for Typhoid Fever - Overview 7 Pipeline Products for Typhoid Fever - Comparative Analysis 8 Typhoid Fever - Therapeutics under Development by Companies 9 Typhoid Fever - Therapeutics under Investigation by Universities/Institutes 10 Typhoid Fever - Pipeline Products Glance 11 Clinical Stage Products 11 Early Stage Products 12 Unknown Stage Products 13 Typhoid Fever - Products under Development by Companies 14 Typhoid Fever - Products under Investigation by Universities/Institutes 15 Typhoid Fever - Companies Involved in Therapeutics Development 16 Chongqing Zhifei Biological Products Co., Ltd. 16 Novartis AG 17 Prokarium Ltd. 18 Shantha Biotechnics Limited 19 Typhoid Fever - Therapeutics Assessment 20 Assessment by Monotherapy Products 20 Assessment by Combination Products 21 Assessment by Target 22 Assessment by Route of Administration 24 Assessment by Molecule Type 26 Drug Profiles 28 Typhella - Drug Profile 28 Product Description 28 Mechanism of Action 28 R&D Progress 28 Typhetec - Drug Profile 30 Product Description 30 Mechanism of Action 30 R&D Progress 30 typhoid + paratyphoid (bivalent) vaccine - Drug Profile 31 Product Description 31 Mechanism of Action 31 R&D Progress 31 typhoid + paratyphoid vaccine - Drug Profile 32 Product Description 32 Mechanism of Action 32 R&D Progress 32 typhoid and paratyphoid fever vaccine - Drug Profile 33 Product Description 33 Mechanism of Action 33 R&D Progress 33 typhoid fever polysaccharide vaccine - Drug Profile 34 Product Description 34 Mechanism of Action 34 R&D Progress 34 Vi-CRM197 - Drug Profile 35 Product Description 35 Mechanism of Action 35 R&D Progress 35 Vi-PspA Vaccine - Drug Profile 36 Product Description 36 Mechanism of Action 36 R&D Progress 36 ViCRM-197 - Drug Profile 37 Product Description 37 Mechanism of Action 37 R&D Progress 37 Typhoid Fever - Recent Pipeline Updates 38 Typhoid Fever - Dormant Projects 40 Typhoid Fever - Discontinued Products 41 Typhoid Fever - Product Development Milestones 42 Featured News & Press Releases 42 Mar 11, 2013: Prokarium And University Of Birmingham Receive �0.4m Grant To Develop Next Generation Vaccines 42 Jun 05, 2008: Emergent BioSolutions Initiates U.S. Phase II Trial of Oral Typhoid Vaccine Candidate 42 Jan 08, 2008: Emergent BioSolutions Announces Final Phase II Clinical Study Results for Typhoid Vaccine 43 Nov 21, 2005: Emergent Biosolutions Starts Clinical Study Of Single-Dose Oral Typhoid Vaccine 43 Aug 30, 2005: Emergent Biosolutions' Typhoid Vaccine Achieves Positive Results In Phase II Clinical Study 44 Appendix 45 Methodology 45 Coverage 45 Secondary Research 45 Primary Research 45 Expert Panel Validation 45 Contact Us 46 Disclaimer 46
List of Tables Number of Products under Development for Typhoid Fever, H1 2015 7 Number of Products under Development for Typhoid Fever - Comparative Analysis, H1 2015 8 Number of Products under Development by Companies, H1 2015 9 Number of Products under Investigation by Universities/Institutes, H1 2015 10 Comparative Analysis by Clinical Stage Development, H1 2015 11 Comparative Analysis by Early Stage Development, H1 2015 12 Comparative Analysis by Unknown Stage Development, H1 2015 13 Products under Development by Companies, H1 2015 14 Products under Investigation by Universities/Institutes, H1 2015 15 Typhoid Fever - Pipeline by Chongqing Zhifei Biological Products Co., Ltd., H1 2015 16 Typhoid Fever - Pipeline by Novartis AG, H1 2015 17 Typhoid Fever - Pipeline by Prokarium Ltd., H1 2015 18 Typhoid Fever - Pipeline by Shantha Biotechnics Limited, H1 2015 19 Assessment by Monotherapy Products, H1 2015 20 Assessment by Combination Products, H1 2015 21 Number of Products by Stage and Target, H1 2015 23 Number of Products by Stage and Route of Administration, H1 2015 25 Number of Products by Stage and Molecule Type, H1 2015 27 Typhoid Fever Therapeutics - Recent Pipeline Updates, H1 2015 38 Typhoid Fever - Dormant Projects, H1 2015 40 Typhoid Fever - Discontinued Products, H1 2015 41
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
